Coronavirus: a Rosario laboratory will produce quick self-tests for guidance

The Wiener Lab laboratory, with a production plant in Rosario, will be the first to produce rapid self-tests for the indicative detection of the coronavirus in the country, it was reported this Friday after receiving approval from the National Administration of Medicines, Food and Medical Technology (Anmat). ) to manufacture this product that will be freely sold in pharmacies and drugstores throughout the country.

“This test makes it possible to determine the presence or absence of antigens (proteins) of the SARS-CoV-2 virus,” explained the company’s president, Federico Rojkin, adding that “it is a simple test that can be performed by anyone over 18 years of age at home. He also clarified “that the result is indicative. It does not confirm or rule out the infection,” said the manager.

Rojkin did not risk the production volumes that the company plans to develop, but admitted that as of Anmat’s approval, the laboratory is working “against the clock” to supply pharmacies and drugstores as soon as possible.

The new production line requires an investment of 85 million pesos from the laboratory to expand production. “Wiener Lab. has more than 300 employees in Rosario. We are working as a team and redirecting all efforts to meet the demand,” said the biochemist who graduated from the National University of Rosario (UNR).

He specified that since the pandemic began, the company – founded 60 years ago by his father, Miguel, also a biochemist and researcher – “manufactured 500,000 PCR tests and 10,000 rapid antigen tests for professional use.” Along these lines, he emphasized “that Winer Lab. is so far the only national company authorized to manufacture and market covid-19 self-tests.”

“Our goal is to provide a national industry tool to all Argentines and, in principle, to be able to supply the local market and all the pharmacies that require it,” he said, not ruling out that the product “later on can be exported to different countries.” of the region where we have 10 subsidiaries of our own,” he stated.

Regarding the retail price of the kits, he said that they will go to the local market for about 3,000 or 4,000 pesos.

The components of the kit are a cassette with lateral flow technology that uses commercial antibodies linked to nanoparticles; includes a swab for taking the nasal sample and a solution for the treatment; and the result can be obtained in 15 minutes.

Disclaimer: If you need to update/edit/remove this news or article then please contact our support team Learn more